PRESTIGE CONSUMER HEALTHCARE INC.

(PBH)
  Report
Delayed Nyse  -  04:00 2022-08-09 pm EDT
57.23 USD   -3.65%
08/04Prestige Consumer Healthcare Inc. Provides Earnings Guidance for the Second Quarter and Full Fiscal Year 2023
CI
08/04TRANSCRIPT : Prestige Consumer Healthcare Inc., Q1 2023 Earnings Call, Aug 04, 2022
CI
08/04Prestige Consumer Healthcare Earnings Decline, Revenue Rises for Q1 of Fiscal 2023
MT
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
08/03/2022 08/04/2022 08/05/2022 08/08/2022 08/09/2022 Date
59.54(c) 58.97(c) 59.35(c) 59.4(c) 57.23(c) Last
498 918 387 487 360 671 210 943 284 522 Volume
-0.96% -0.96% +0.64% +0.08% -3.65% Change
More quotes
Estimated financial data (e) (USD)
Sales 2023 1 124 M - -
Net income 2023 213 M - -
Net Debt 2023 - - -
P/E ratio 2023 13,6x
Yield 2023 -
Sales 2024 1 150 M - -
Net income 2024 228 M - -
Net Debt 2024 - - -
P/E ratio 2024 12,7x
Yield 2024 -
Capitalization 2 848 M 2 848 M -
Capi. / Sales 2023 2,53x
Capi. / Sales 2024 2,48x
Nbr of Employees 535
Free-Float 90,2%
More Financials
Company
Prestige Brands Holdings, Inc. is engaged in the development, manufacturing, marketing, sales and distribution of over-the-counter (OTC) health and personal care products to mass merchandisers, drug, food, dollar, convenience, club and e-commerce stores in North America (the United States and Canada) and in Australia and certain other international markets. The Company operates through two segments: North American... 
Sector
Pharmaceuticals
Calendar
11/03Earnings Release
More about the company
Ratings of Prestige Consumer Healthcare Inc.
Trading Rating : 
Investor Rating : 
ESG Refinitiv : 
C+
More Ratings
All news about PRESTIGE CONSUMER HEALTHCARE INC.
08/04Prestige Consumer Healthcare Inc. Provides Earnings Guidance for the Second Quarter and..
CI
08/04TRANSCRIPT : Prestige Consumer Healthcare Inc., Q1 2023 Earnings Call, Aug 04, 2022
CI
08/04Prestige Consumer Healthcare Earnings Decline, Revenue Rises for Q1 of Fiscal 2023
MT
08/04PRESTIGE CONSUMER HEALTHCARE : Reports Results for First Quarter Fiscal 2023 - Form 8-K
PU
08/04PRESTIGE CONSUMER HEALTHCARE INC. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CO..
AQ
08/04PRESTIGE BRANDS : Fiscal Q1 Earnings Snapshot
AQ
08/04PRESTIGE CONSUMER HEALTHCARE INC. : Results of Operations and Financial Condition, Regulat..
AQ
08/04Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Reports Q1 Revenue $277.1M
MT
08/04Prestige Consumer Healthcare Inc. Reports Results for First Quarter Fiscal 2023
GL
08/04Prestige Consumer Healthcare Inc. Reports Results for First Quarter Fiscal 2023
GL
08/04Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE Reports Q1 EPS $1.09
MT
08/04Prestige Consumer Healthcare Inc. Reports Earnings Results for the First Quarter Ended ..
CI
08/01Oppenheimer Adjusts Price Target on Prestige Consumer Healthcare to $68 From $63, Maint..
MT
07/11Prestige Consumer Healthcare Inc. to Release Fiscal 2023 First Quarter Earnings Results
GL
07/11Prestige Consumer Healthcare Inc. to Release Fiscal 2023 First Quarter Earnings Results
GL
More news
News in other languages on PRESTIGE CONSUMER HEALTHCARE INC.
08/04Prestige Consumer Healthcare Inc. fournit des prévisions de bénéfices pour le deuxième ..
08/04Baisse des bénéfices de Prestige Consumer Healthcare, hausse des revenus pour le 1er tr..
08/04Earnings Flash (PBH) PRESTIGE CONSUMER HEALTHCARE annonce un chiffre d'affaires de 277,..
08/04Prestige Consumer Healthcare Inc. annonce ses résultats pour le premier trimestre clos ..
05/05Prestige Consumer Healthcare Inc. annonce ses résultats financiers pour le quatrième tr..
More news
Analyst Recommendations on PRESTIGE CONSUMER HEALTHCARE INC.
More recommendations
Chart PRESTIGE CONSUMER HEALTHCARE INC.
Duration : Period :
Prestige Consumer Healthcare Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends PRESTIGE CONSUMER HEALTHCARE INC.
Short TermMid-TermLong Term
TrendsNeutralBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 6
Last Close Price 57,23 $
Average target price 67,60 $
Spread / Average Target 18,1%
EPS Revisions
Managers and Directors
Ronald M. Lombardi Chairman, President & Chief Executive Officer
Christine Sacco Chief Financial Officer
Jeff Zerillo Senior Vice President-Operations
John E. Byom Independent Director
Sheila A. Hopkins Independent Director
Sector and Competitors
1st jan.Capi. (M$)
PRESTIGE CONSUMER HEALTHCARE INC.-5.64%2 848
JOHNSON & JOHNSON-0.52%447 434
ELI LILLY AND COMPANY9.70%287 922
PFIZER, INC.-16.05%279 310
ROCHE HOLDING AG-16.02%275 991
ABBVIE INC.3.58%247 976